Aptose Biosciences Inc. (APTO)

NASDAQ: APTO · Real-Time Price · USD

1.710

-1.455 (-45.97%)

At close: Apr 1, 2025, 4:00 PM

1.650

-0.060 (-3.51%)

After-hours: Apr 1, 2025, 4:53 PM EDT

Aptose Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Selling, General & Admin	11.15	15.59	14.51	19.46	26.48	Upgrade
Research & Development	15.1	36.77	28.09	45.99	29.29	Upgrade
Operating Expenses	26.26	52.36	42.6	65.45	55.77	Upgrade
Operating Income	-26.26	-52.36	-42.6	-65.45	-55.77	Upgrade
Interest & Investment Income	-	1.15	0.79	0.09	0.52	Upgrade
Currency Exchange Gain (Loss)	-	-0	-0.01	-0	0.01	Upgrade
Other Non Operating Income (Expenses)	0.83	-	-	-	-	Upgrade
Pretax Income	-25.43	-51.21	-41.82	-65.35	-55.24	Upgrade
Net Income	-25.43	-51.21	-41.82	-65.35	-55.24	Upgrade
Net Income to Common	-25.43	-51.21	-41.82	-65.35	-55.24	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	0	0	0	0	Upgrade
Shares Change (YoY)	210.43%	9.82%	3.57%	8.86%	63.15%	Upgrade
EPS (Basic)	-36.38	-227.42	-203.98	-330.12	-303.74	Upgrade
EPS (Diluted)	-36.38	-227.42	-203.98	-330.12	-303.74	Upgrade
Free Cash Flow	-	-44.62	-32.35	-43.52	-33.97	Upgrade
Free Cash Flow Per Share	-	-198.16	-157.76	-219.81	-186.79	Upgrade
EBITDA	-26.22	-52.27	-42.48	-65.3	-55.62	Upgrade
D&A For EBITDA	0.04	0.09	0.12	0.15	0.15	Upgrade
EBIT	-26.26	-52.36	-42.6	-65.45	-55.77	Upgrade

Updated Nov 9, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q